Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
Clinical trial NCT06333951 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06333951
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-17
- Primary completion
- 2026-10-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.